BTA short-course chemotherapy studies.
D002986:Clinical Trials as Topic; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006505:Hepatitis / Q000150:complications; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D008111:Liver Function Tests; D008297:Male; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy*; D006113:United Kingdom
D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin